For
UK
audiences
The comprehensive guide to wound product selection
The comprehensive guide to wound product selection
Multicomponent compression bandage system that combines elastic and inelastic components. Designed to provide sustained graduated compression for up to 7 days. The first-layer, K-Tech, is a short-stretch (inelastic) bandage that delivers stiffness, absorbency and 80% of the pressure. The second-layer, K-Press, is an elastic, cohesive bandage that keeps the system in place and provides additional compression to achieve therapeutic pressure. The combined effect is designed to provide continuous, consistent and comfortable compression, both when active and at rest.
Multicomponent compression bandage system that combines elastic and inelastic components. Provides sustained graduated compression for up to 7 days. The first layer, KTech, is a short-stretch (inelastic) bandage that delivers stiffness, absorbency and 80% of the pressure. The second-layer, K-Press, is an elastic, cohesive bandage that keeps the system in place and provides additional compression to provide therapeutic pressure. The combined effect is designed to provide continuous, consistent and comfortable compression, both when active and at rest. Donates an average pressure of 20mmHg at the ankle. Also available in latex-free.
Multicomponent compression bandaging kit that combines UrgoKTwo with UrgoStart Contact
A highly absorbent sterile dressing composed of ‘G- type’ calcium alginate fibres and hydrocolloid particles
A highly absorbent antibacterial sterile silver dressing, that is also composed of ‘G- type’ calcium alginate fibres and hydrocolloid particles
Lipido-colloid foam dressing with soft-adherent TLC-NOSF Healing Matrix that jellifies in contact with wound exudate, reducing MMP levels and restoring balance to close wounds sooner. Also contains an absorbent polyurethane foam pad. NICE 2019 medical technology guidance (MTG42) states that evidence supports the case for adopting UrgoStart dressings to treat diabetic foot ulcers and venous leg ulcers.
Lipido-colloid foam dressing with soft-adherent TLC-NOSF Healing Matrix that jellifies in contact with wound exudate, reducing MMP levels and restoring balance to close wounds sooner. Also contains an absorbent polyurethane foam pad and a protective non-woven polyurethane backing. NICE 2019 medical technology guidance (MTG42) states that evidence supports the case for adopting UrgoStart dressings to treat diabetic foot ulcers and venous leg ulcers.
Flexible lipido-colloid non-occlusive contact layer containing TLC-NOSF Healing Matrix that jellifies in contact with wound exudate, reducing MMP levels and restoring balance to close wounds sooner. NICE 2019 medical technology guidance (MTG42) states that evidence supports the case for adopting UrgoStart dressings to treat diabetic foot ulcers and venous leg ulcers.
The poly-absorbent pad and the super-absorbent layer in UrgoStart Plus Absorb ensure a high absorption and fluid management of exudate preventing maceration. The dressing can be used under compression bandage when prescribed.
Polyabsorbent fibre dressing containing soft-adherent TLC-NOSF Healing Matrix that jellifies in contact with wound exudate, reducing MMP levels and restoring balance to close wounds sooner. The polyabsorbent fibres bind, trap and retain exudate, slough and debris. Also contains a superabsorbent layer and a silicone border with showerproof backing. NICE 2019 medical technology guidance (MTG42) states that evidence supports the case for adopting UrgoStart dressings to treat diabetic foot ulcers and venous leg ulcers.
